UC San Diego names new radiology chair, GE CEO change, plus more leadership moves
The University of California San Diego School of Medicine on Feb. 28 named Christine B. Chung, MD, as the next chair of its Department of Radiology.
Chung has served as interim leader of the section since December 2023, replacing the departing Alexander Norbash, MD. She first joined UC San Diego in 1998 as an osteoradiology fellow and became part of the faculty as an assistant professor the following year.
Chung has published over 200 peer-reviewed manuscripts and has a long history of securing grant funding for her work. As chair, she plans to focus on thoughtful implementation of artificial intelligence to improve department efficiencies and better serve patients.
“We will focus on developing the best technology to deliver quality healthcare,” Chung said in a statement. “By leveraging the expertise of our team, we will be able to identify targets for AI and partnerships that will allow us to focus on engaging each other and our patients. “
UC San Diego said the department also plans to expand access to diagnostic and interventional radiology services under Chung’s management. “Imaging is a central, core service and without high quality imaging, patient care cannot realize its full potential,” she added.
Chung previously held several other leadership roles, including director of the UC San Diego Musculoskeletal Imaging Research Group and vice chair for academic affairs in the department. She also is a fellow of the International Society for Magnetic Resonance in Medicine, active member of several other organizations, and president-elect of the International Skeletal Society.
Barbara Jung, MD, associate vice chancellor and dean of UCSD School of Medicine, said the appointment marks an “exciting milestone” for the organization.
“With her leadership we are confident that the department will continue to push boundaries in innovation and excellence, shaping the future of radiology and the next generation of healthcare professionals."
GE names new China CEO
GE HealthCare on Feb. 27 named Will Song, a leader at Johnson & Johnson for the past 20 years, as its new CEO in China beginning next month.
He replaces Yihao Zhang, who will retire effective July 1. At J&J, Song served as global senior VP and China chairman, holding various positions at the company since first starting there in 2003.
Zhang joined GE in 2019, leading its strategic development and operations in China. GE highlighted his accomplishments—doubling investments in innovation within five years, expanding the company’s footprint across China and building two new manufacturing sites.
“Yihao has proven himself to be a humble, energetic, people-focused leader who embraced our company culture, strategy and purpose,” Peter Arduini, president and CEO of GE HealthCare, said in a statement. “He has made an indelible mark on our colleagues and the industry.”
Other appointments
A few more radiology-related appointments of note, in brief:
- South Korean AI vendor Lunit on Feb. 26 announced it has hired Craig Hadfield as the new CEO of subsidiary, Volpara, which it acquired last year for $193 million.
- ClearView Imaging Center in Florida on March 4 announced the appointment of Fred H. Brennan Jr., DO, as its medical director.
- Vanderbilt University Medical Center on March 3 announced the hiring of Eric Wallace, MD, as vice chair of community radiology and associate professor.
- The American Roentgen Ray Society on March 5 named Tanya W. Moseley, MD, as the 2025 winner of its Distinguished Educator Award.
- And finally, radiology vendor Sirona Medical recently named IT veteran Ken Kaufman as its next CEO.
Marty Stempniak has covered healthcare since 2012, with his byline appearing in the American Hospital Association's member magazine, Modern Healthcare and McKnight's. Prior to that, he wrote about village government and local business for his hometown newspaper in Oak Park, Illinois. He won a Peter Lisagor and Gold EXCEL awards in 2017 for his coverage of the opioid epidemic.